 Steven Edmundowicz
Concepts (469)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy, Gastrointestinal | 29 | 2023 | 203 | 3.930 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 35 | 2024 | 180 | 3.510 |
Why?
| | Endosonography | 29 | 2023 | 140 | 2.180 |
Why?
| | Bariatric Surgery | 12 | 2019 | 161 | 2.080 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 273 | 1.910 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 731 | 1.890 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 110 | 1.850 |
Why?
| | Adenoma | 12 | 2023 | 189 | 1.610 |
Why?
| | Endoscopy | 13 | 2020 | 246 | 1.600 |
Why?
| | Weight Loss | 11 | 2019 | 642 | 1.530 |
Why?
| | Obesity | 17 | 2019 | 2508 | 1.500 |
Why?
| | Gastric Balloon | 6 | 2018 | 12 | 1.440 |
Why?
| | Gastroplasty | 5 | 2019 | 26 | 1.340 |
Why?
| | Adenocarcinoma | 13 | 2023 | 795 | 1.250 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 102 | 1.220 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 65 | 1.150 |
Why?
| | Barrett Esophagus | 10 | 2022 | 147 | 1.150 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 215 | 1.100 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 52 | 1.080 |
Why?
| | Drainage | 11 | 2023 | 151 | 1.010 |
Why?
| | Gastroenterology | 10 | 2019 | 159 | 1.000 |
Why?
| | Colonoscopy | 12 | 2023 | 204 | 0.990 |
Why?
| | Colonic Polyps | 7 | 2015 | 67 | 0.990 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 234 | 0.910 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 56 | 0.900 |
Why?
| | Pancreatitis | 11 | 2024 | 107 | 0.830 |
Why?
| | Stents | 16 | 2024 | 475 | 0.810 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 182 | 0.770 |
Why?
| | Pancreatic Ducts | 8 | 2022 | 69 | 0.750 |
Why?
| | Cholestasis | 3 | 2020 | 225 | 0.750 |
Why?
| | Duodenum | 4 | 2019 | 62 | 0.720 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.720 |
Why?
| | Obesity, Morbid | 7 | 2019 | 197 | 0.710 |
Why?
| | Humans | 156 | 2024 | 114686 | 0.710 |
Why?
| | Esophagus | 8 | 2019 | 225 | 0.700 |
Why?
| | Middle Aged | 88 | 2022 | 26737 | 0.690 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 64 | 0.670 |
Why?
| | Clinical Competence | 11 | 2020 | 893 | 0.670 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 20 | 0.670 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 64 | 0.650 |
Why?
| | Pancreatic Pseudocyst | 4 | 2018 | 13 | 0.620 |
Why?
| | Aged | 67 | 2022 | 19074 | 0.610 |
Why?
| | Cross Infection | 1 | 2020 | 197 | 0.600 |
Why?
| | Gastrostomy | 5 | 2019 | 91 | 0.580 |
Why?
| | Learning Curve | 6 | 2019 | 63 | 0.580 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 22 | 0.570 |
Why?
| | Radiation Exposure | 1 | 2017 | 41 | 0.570 |
Why?
| | Intestine, Small | 2 | 2020 | 122 | 0.570 |
Why?
| | Prospective Studies | 35 | 2023 | 6220 | 0.560 |
Why?
| | Colonic Diseases | 3 | 2013 | 25 | 0.550 |
Why?
| | Radiation Injuries | 1 | 2017 | 128 | 0.540 |
Why?
| | Jejunum | 2 | 2015 | 24 | 0.530 |
Why?
| | Treatment Outcome | 34 | 2023 | 9088 | 0.520 |
Why?
| | Male | 89 | 2023 | 55596 | 0.510 |
Why?
| | Smell | 1 | 2016 | 111 | 0.510 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 14 | 0.510 |
Why?
| | Pathology, Clinical | 1 | 2015 | 32 | 0.500 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 59 | 0.500 |
Why?
| | Pancreas | 7 | 2021 | 276 | 0.500 |
Why?
| | Laparoscopy | 6 | 2020 | 398 | 0.490 |
Why?
| | Female | 91 | 2023 | 59507 | 0.490 |
Why?
| | Pancreatitis, Chronic | 4 | 2022 | 40 | 0.490 |
Why?
| | Cholelithiasis | 8 | 2010 | 31 | 0.490 |
Why?
| | Suction | 2 | 2017 | 31 | 0.470 |
Why?
| | Catheter Ablation | 5 | 2022 | 288 | 0.470 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 74 | 0.460 |
Why?
| | Esophagoscopy | 8 | 2022 | 184 | 0.440 |
Why?
| | Gallstones | 6 | 1996 | 28 | 0.440 |
Why?
| | Adult | 58 | 2024 | 30550 | 0.430 |
Why?
| | Lithotripsy | 5 | 2019 | 40 | 0.430 |
Why?
| | Catheterization | 8 | 2019 | 159 | 0.420 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2096 | 0.420 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1692 | 0.410 |
Why?
| | Propofol | 4 | 2023 | 43 | 0.410 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 615 | 0.400 |
Why?
| | Body Weight | 1 | 2016 | 869 | 0.400 |
Why?
| | Biopsy | 5 | 2019 | 1036 | 0.380 |
Why?
| | Precancerous Conditions | 4 | 2017 | 158 | 0.380 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.370 |
Why?
| | Aged, 80 and over | 22 | 2019 | 6347 | 0.370 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 287 | 0.360 |
Why?
| | Postoperative Complications | 10 | 2021 | 2128 | 0.360 |
Why?
| | Bile Ducts | 5 | 2014 | 68 | 0.350 |
Why?
| | Indomethacin | 2 | 2024 | 70 | 0.350 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 19 | 0.350 |
Why?
| | Ampulla of Vater | 3 | 2023 | 30 | 0.340 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 47 | 0.340 |
Why?
| | Cytodiagnosis | 2 | 2020 | 29 | 0.340 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 11 | 0.330 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 208 | 0.330 |
Why?
| | Insufflation | 1 | 2009 | 9 | 0.330 |
Why?
| | Retrospective Studies | 34 | 2023 | 12550 | 0.320 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 309 | 0.310 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 24 | 0.310 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 42 | 0.310 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 46 | 0.310 |
Why?
| | Carbon Dioxide | 1 | 2009 | 218 | 0.290 |
Why?
| | Pain, Postoperative | 1 | 2009 | 191 | 0.290 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.290 |
Why?
| | Decompression, Surgical | 2 | 2023 | 93 | 0.280 |
Why?
| | Body Mass Index | 7 | 2019 | 1959 | 0.280 |
Why?
| | Pancreatectomy | 2 | 2021 | 171 | 0.280 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 138 | 0.270 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 43 | 0.270 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 24 | 0.270 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 858 | 0.270 |
Why?
| | Follow-Up Studies | 16 | 2015 | 4411 | 0.270 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 12 | 0.260 |
Why?
| | Thoracoscopy | 1 | 2006 | 57 | 0.260 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 328 | 0.260 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 85 | 0.250 |
Why?
| | Mental Recall | 1 | 2006 | 171 | 0.250 |
Why?
| | Societies, Medical | 3 | 2018 | 664 | 0.240 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 10 | 0.230 |
Why?
| | Polyvinyls | 1 | 2004 | 17 | 0.230 |
Why?
| | Plastics | 3 | 2022 | 35 | 0.230 |
Why?
| | Magnets | 2 | 2015 | 15 | 0.230 |
Why?
| | Periodicals as Topic | 1 | 2006 | 181 | 0.220 |
Why?
| | Gastric Bypass | 2 | 2017 | 92 | 0.220 |
Why?
| | Ablation Techniques | 3 | 2017 | 29 | 0.210 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.210 |
Why?
| | Internet | 2 | 2009 | 596 | 0.210 |
Why?
| | Patient Satisfaction | 1 | 2006 | 578 | 0.210 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 211 | 0.200 |
Why?
| | Fluoroscopy | 3 | 2019 | 139 | 0.200 |
Why?
| | Anesthesia | 1 | 2023 | 117 | 0.200 |
Why?
| | Prostheses and Implants | 3 | 2013 | 137 | 0.200 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 15 | 0.190 |
Why?
| | Deglutition Disorders | 3 | 2019 | 118 | 0.190 |
Why?
| | Double-Blind Method | 7 | 2018 | 1660 | 0.190 |
Why?
| | Prosthesis Design | 3 | 2019 | 285 | 0.180 |
Why?
| | Quality of Life | 10 | 2019 | 2353 | 0.180 |
Why?
| | Intestinal Perforation | 2 | 2018 | 39 | 0.180 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 37 | 0.180 |
Why?
| | Varicose Veins | 1 | 2020 | 14 | 0.180 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1167 | 0.180 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 31 | 0.170 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 32 | 0.170 |
Why?
| | Deep Sedation | 2 | 2010 | 10 | 0.170 |
Why?
| | Abdominal Pain | 3 | 2019 | 135 | 0.170 |
Why?
| | Cell-Free System | 1 | 2019 | 47 | 0.170 |
Why?
| | Equipment Design | 6 | 2020 | 508 | 0.170 |
Why?
| | Liver Neoplasms | 1 | 2023 | 506 | 0.170 |
Why?
| | Fiducial Markers | 1 | 2019 | 8 | 0.160 |
Why?
| | Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1395 | 0.160 |
Why?
| | Watchful Waiting | 3 | 2019 | 55 | 0.160 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 30 | 0.160 |
Why?
| | Academic Medical Centers | 3 | 2023 | 411 | 0.160 |
Why?
| | Needles | 1 | 2019 | 49 | 0.160 |
Why?
| | Infection Control | 1 | 2020 | 135 | 0.160 |
Why?
| | Metals | 4 | 2023 | 106 | 0.160 |
Why?
| | Reproducibility of Results | 7 | 2020 | 2764 | 0.160 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 45 | 0.150 |
Why?
| | Abdomen | 2 | 2016 | 99 | 0.150 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 299 | 0.150 |
Why?
| | Simulation Training | 1 | 2019 | 61 | 0.150 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.150 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 70 | 0.150 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 368 | 0.150 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 13 | 0.150 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.140 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 14 | 0.140 |
Why?
| | Suture Techniques | 3 | 2017 | 115 | 0.140 |
Why?
| | Conscious Sedation | 2 | 2023 | 78 | 0.140 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 133 | 0.140 |
Why?
| | Logistic Models | 6 | 2021 | 1841 | 0.140 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 87 | 0.140 |
Why?
| | Calcinosis | 1 | 2019 | 242 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 88 | 0.140 |
Why?
| | Immunoassay | 1 | 2017 | 95 | 0.140 |
Why?
| | Metaplasia | 4 | 2022 | 54 | 0.140 |
Why?
| | Diet Therapy | 1 | 2016 | 36 | 0.140 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 993 | 0.140 |
Why?
| | Referral and Consultation | 3 | 2019 | 635 | 0.130 |
Why?
| | Population Surveillance | 2 | 2017 | 392 | 0.130 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 290 | 0.130 |
Why?
| | Stomach | 1 | 2016 | 102 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 227 | 0.130 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 532 | 0.130 |
Why?
| | Pilot Projects | 2 | 2013 | 1373 | 0.130 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 25 | 0.130 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.130 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 56 | 0.130 |
Why?
| | Risk Factors | 11 | 2024 | 8632 | 0.130 |
Why?
| | Single-Blind Method | 5 | 2019 | 258 | 0.130 |
Why?
| | Dogs | 1 | 2016 | 334 | 0.130 |
Why?
| | Life Style | 2 | 2018 | 430 | 0.130 |
Why?
| | Documentation | 1 | 2017 | 167 | 0.130 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.120 |
Why?
| | Dissection | 1 | 2015 | 51 | 0.120 |
Why?
| | Young Adult | 10 | 2018 | 10469 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 52 | 0.120 |
Why?
| | Cholecystectomy | 4 | 2009 | 45 | 0.120 |
Why?
| | Leiomyoma | 1 | 2015 | 44 | 0.120 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 96 | 0.120 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1040 | 0.120 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.120 |
Why?
| | Aptitude | 1 | 2014 | 38 | 0.120 |
Why?
| | Colorectal Surgery | 1 | 2014 | 21 | 0.120 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 227 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1430 | 0.110 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 1796 | 0.110 |
Why?
| | Ulcer | 1 | 2014 | 28 | 0.110 |
Why?
| | Colectomy | 1 | 2014 | 86 | 0.110 |
Why?
| | Hemorrhage | 1 | 2018 | 620 | 0.110 |
Why?
| | Patient Safety | 1 | 2016 | 277 | 0.110 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 15 | 0.110 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 25 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 26 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2016 | 352 | 0.110 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 123 | 0.110 |
Why?
| | Contrast Media | 1 | 1995 | 345 | 0.110 |
Why?
| | Recurrence | 4 | 2020 | 935 | 0.100 |
Why?
| | Risk Assessment | 8 | 2016 | 2968 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 212 | 0.100 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 15 | 0.100 |
Why?
| | Health Care Costs | 1 | 2015 | 381 | 0.100 |
Why?
| | Cholecystitis | 1 | 1992 | 17 | 0.100 |
Why?
| | Lymph Nodes | 2 | 2012 | 419 | 0.100 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 5 | 0.100 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1342 | 0.100 |
Why?
| | Diverticulum | 1 | 1991 | 11 | 0.100 |
Why?
| | Digestive System Diseases | 1 | 2011 | 23 | 0.100 |
Why?
| | Duodenal Diseases | 1 | 1991 | 9 | 0.100 |
Why?
| | Time Factors | 8 | 2019 | 6115 | 0.100 |
Why?
| | United States | 10 | 2018 | 12183 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 24 | 0.090 |
Why?
| | Sensation | 1 | 1991 | 44 | 0.090 |
Why?
| | Proteomics | 1 | 2017 | 836 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2539 | 0.090 |
Why?
| | Chest Pain | 1 | 1991 | 81 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 525 | 0.090 |
Why?
| | Administration, Rectal | 2 | 2024 | 5 | 0.090 |
Why?
| | Deglutition | 1 | 1991 | 58 | 0.090 |
Why?
| | Disease Progression | 5 | 2017 | 2380 | 0.090 |
Why?
| | Hypotension | 1 | 2011 | 116 | 0.090 |
Why?
| | Image Enhancement | 1 | 2011 | 159 | 0.090 |
Why?
| | Muscle, Smooth | 1 | 1991 | 144 | 0.090 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 6 | 0.090 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.090 |
Why?
| | Bile | 1 | 2009 | 26 | 0.090 |
Why?
| | Cholecystostomy | 1 | 1989 | 4 | 0.090 |
Why?
| | Odds Ratio | 4 | 2016 | 953 | 0.080 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 74 | 0.080 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 73 | 0.080 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 26 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3346 | 0.080 |
Why?
| | Anesthetics | 1 | 2009 | 54 | 0.080 |
Why?
| | Tumor Burden | 3 | 2015 | 259 | 0.080 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 40 | 0.080 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 40 | 0.080 |
Why?
| | Equipment Safety | 2 | 2009 | 39 | 0.080 |
Why?
| | Incidence | 5 | 2018 | 2313 | 0.080 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 157 | 0.080 |
Why?
| | Cholangiography | 1 | 2008 | 17 | 0.080 |
Why?
| | Ultrasonography | 4 | 1996 | 634 | 0.080 |
Why?
| | Choledocholithiasis | 1 | 2008 | 14 | 0.080 |
Why?
| | Feeding Behavior | 1 | 2013 | 574 | 0.070 |
Why?
| | Video Recording | 3 | 2014 | 143 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 311 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 371 | 0.070 |
Why?
| | Registries | 1 | 2015 | 1768 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 259 | 0.070 |
Why?
| | Acute Disease | 4 | 2008 | 911 | 0.070 |
Why?
| | Biopsy, Needle | 2 | 2004 | 182 | 0.070 |
Why?
| | Delphi Technique | 2 | 2017 | 160 | 0.070 |
Why?
| | Prognosis | 5 | 2017 | 3329 | 0.070 |
Why?
| | Research Design | 2 | 2016 | 928 | 0.070 |
Why?
| | Adolescent | 7 | 2024 | 17844 | 0.070 |
Why?
| | Hyperplasia | 2 | 2019 | 163 | 0.070 |
Why?
| | Pleural Diseases | 1 | 2006 | 20 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 21 | 0.060 |
Why?
| | Hypoxia | 1 | 2011 | 958 | 0.060 |
Why?
| | Cohort Studies | 5 | 2020 | 4895 | 0.060 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 4623 | 0.060 |
Why?
| | Pain | 2 | 2022 | 705 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 23 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 539 | 0.060 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 126 | 0.060 |
Why?
| | Cyst Fluid | 2 | 2018 | 27 | 0.060 |
Why?
| | Diphenhydramine | 1 | 2023 | 30 | 0.060 |
Why?
| | Midazolam | 1 | 2023 | 43 | 0.060 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 125 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 577 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1004 | 0.050 |
Why?
| | Animals | 3 | 2020 | 31706 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 296 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 65 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 15 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 61 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2097 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 38 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 134 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 211 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2286 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 16 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 243 | 0.050 |
Why?
| | Length of Stay | 4 | 2018 | 962 | 0.050 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 65 | 0.050 |
Why?
| | Endoscopes | 2 | 1998 | 18 | 0.050 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 48 | 0.050 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 39 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 210 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2018 | 740 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 20 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1121 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 36 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 40 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 56 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 53 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 29 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 85 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 932 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 6 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 304 | 0.040 |
Why?
| | General Surgery | 1 | 2000 | 127 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 60 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1183 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1177 | 0.040 |
Why?
| | Radiology | 1 | 2000 | 141 | 0.040 |
Why?
| | Probability | 2 | 2009 | 289 | 0.040 |
Why?
| | Electrodes | 1 | 1998 | 100 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 43 | 0.040 |
Why?
| | Swine | 1 | 2020 | 700 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 252 | 0.040 |
Why?
| | Reference Standards | 1 | 2018 | 159 | 0.040 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 72 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2018 | 47 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 385 | 0.040 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 89 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 154 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2251 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 68 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 62 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2387 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 176 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 9116 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 4 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1644 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 9 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 11 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 17 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 13 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 517 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 2 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 37 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 27 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 13 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 94 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 81 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 31 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3052 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 800 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 77 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 101 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 114 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 173 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 226 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 64 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 196 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 537 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 580 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 233 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 70 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 305 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 160 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 79 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 208 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2018 | 617 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 442 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 359 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 249 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1078 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 407 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 156 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 641 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 544 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 822 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 668 | 0.030 |
Why?
| | Palliative Care | 1 | 2019 | 644 | 0.030 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 4 | 0.030 |
Why?
| | Radio Waves | 2 | 2003 | 16 | 0.030 |
Why?
| | Colic | 1 | 1992 | 6 | 0.030 |
Why?
| | Medicare | 1 | 2017 | 665 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2013 | 108 | 0.030 |
Why?
| | Esophagitis | 1 | 2013 | 65 | 0.030 |
Why?
| | Mediastinum | 1 | 2012 | 22 | 0.030 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 1538 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 355 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 27 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 198 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 11 | 0.020 |
Why?
| | Edema | 1 | 2011 | 119 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 9 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 180 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 319 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1080 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 295 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Methods | 1 | 1989 | 58 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 36 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 511 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 812 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 743 | 0.020 |
Why?
| | Injections | 1 | 2010 | 159 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 482 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 9 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 63 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 811 | 0.020 |
Why?
| | Light | 1 | 2011 | 336 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 342 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 256 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 337 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 113 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 389 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 138 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 157 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 2894 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 228 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 155 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 782 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 1644 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 122 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 109 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 217 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 308 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2008 | 106 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 4409 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1211 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1226 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 608 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1629 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7963 | 0.020 |
Why?
| | Child | 2 | 2018 | 18414 | 0.020 |
Why?
| | Comorbidity | 1 | 2009 | 1448 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 79 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 1715 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 48 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 514 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 975 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 7 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 38 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 47 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 873 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 106 | 0.010 |
Why?
| | Safety | 1 | 1998 | 297 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 26 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 81 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 122 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 560 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 10 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 5 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 115 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 70 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 152 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1578 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 5518 | 0.010 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|